Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences

被引:4
|
作者
Liu, Shaonan [1 ]
Lai, Jiaqi [1 ]
Wu, Lei [2 ]
Guo, Xinfeng [1 ]
机构
[1] Guangzhou Univ Chinese Med, Evidence Based Med & Clin Res Serv Grp, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Resp Dept, Guangzhou, Guangdong, Peoples R China
来源
基金
国家重点研发计划;
关键词
patient preference; Chinese medicine; COPD; COPD; EXACERBATIONS; PERCEPTION; MEDICATION; CARE; NONADHERENCE; ADHERENCE; PHYSICIAN; SYMPTOMS; GRANULES;
D O I
10.2147/PPA.S316872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The patient's preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed to explore preferences and factors associated with CM among COPD patients. Patients and Methods: A pilot survey was conducted among COPD patients using a structured, pre-tested questionnaire. The perceptions of CM therapies (including herbal medicine, non-pharmacotherapies), and expected clinical outcomes were investigated based on patient preference. Factors associated with preference of treatment scenarios were estimated in order of importance. Results: Thirty patients were enrolled in the survey, including 27 males and 3 females. Two-thirds of the patients preferred integrative Chinese and Western medicine for the treatment of COPD. Chinese patent medicines and CM decoction therapy were more popular than CM injections. The preferred non-drug therapy was point application, followed by acupuncture, Tai chi, or Qigong. More than 70% of patients reported that important clinical outcomes were improvements in lung function (77%) and dyspnea, cough, and sputum symptoms (73%), followed by exercise endurance (50%). Besides clinical efficacy, costs and side effects were also important factors for treatment selection. Conclusion: This pilot study showed that Chinese patent medicine and CM decoctions were preferred options for complementary medicines to combine with routine pharmacotherapy for COPD treatment according to the patients' preferences. The improvement of dyspnea, cough symptoms, and lung function was the most desired clinical outcomes for patients. Quicker symptom relief, lower costs, and fewer side effects were key attributes for the treatment selection. Further research with a larger sample size is needed to definitively address the comprehensive conclusion.
引用
收藏
页码:1529 / 1535
页数:7
相关论文
共 50 条
  • [1] CHINESE HERBAL MEDICINE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Shergis, J. L.
    Zhang, A. L.
    Liu, S.
    Chen, X.
    Xue, C. C.
    RESPIROLOGY, 2014, 19 : 25 - 25
  • [2] Guidelines for Chinese Medicine Rehabilitation of Chronic Obstructive Pulmonary Disease
    Jian-Sheng Li
    World Journal of Traditional Chinese Medicine, 2020, 6 (03) : 295 - 306
  • [3] Safety of Chinese Herbal Medicine for Chronic Obstructive Pulmonary Disease
    Coyle, Meaghan
    Shergis, Johannah Linda
    Liu, Shaonan
    Wu, Lei
    Zhang, Anthony Lin
    Guo, Xinfeng
    Lu, Chuanjian
    Xue, Charlie Changli
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [4] Chinese medicine ShenqiBufei attenuates chronic obstructive pulmonary disease
    Zhang, Kui
    Wu, Guiying
    Zhang, Xiangyan
    Yang, Ping
    Yang, Zhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1661 - 1669
  • [5] Guidelines for Chinese medicine rehabilitation of chronic obstructive pulmonary disease
    Li, Jian-Sheng
    WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2020, 6 (03) : 295 - 306
  • [6] Microthrombi in a severe chronic obstructive pulmonary disease patient cohort: A pilot histological study
    Clamp, I. J.
    Booth, G. C.
    Foster, M. L.
    THORAX, 2006, 61 : II63 - II64
  • [7] Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease
    Cao, Xia
    Wang, Yi
    Chen, Ying
    Zhao, Mantong
    Liang, Lanyuan
    Yang, Mengru
    Li, Jianhua
    Peng, Mingming
    Li, Wei
    Yue, Yiming
    Zhang, Han
    Li, Chuanqiu
    Shu, Zunpeng
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 307
  • [8] Traditional Chinese medicine nursing protocols for chronic obstructive pulmonary disease
    Editorial Board of Nursing of Integrated Traditional Chinese and Western Medicine
    中西医结合护理(中英文), 2020, 6 (04) : 241 - 246
  • [9] A pilot study of the multiherb Kampo medicine bakumondoto for cough in patients with chronic obstructive pulmonary disease
    Mukaida, Kenichi
    Hattori, Noboru
    Kondo, Keiichi
    Morita, Naoki
    Murakami, Isao
    Haruta, Yoshihiro
    Yokoyama, Akihito
    Kohno, Nobuoki
    PHYTOMEDICINE, 2011, 18 (8-9) : 625 - 629
  • [10] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
    Nicholas W Morrell
    Matthew A Higham
    Peter G Phillips
    B Haleema Shakur
    Paul J Robinson
    Ray J Beddoes
    Respiratory Research, 6